Jason Alger, Chief Financial Officer at Health Catalyst, Inc. (HCAT), sold 2,899 shares at $7.39 ($21K) on 2024-09-06, disclosed to the SEC on 2024-09-10.
Scheduled sale ($21k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HCAT | SELL | 2023-12-07 | $16K | — | Filing → |
| HCAT | SELL | 2023-09-06 | $26K | — | Filing → |
| HCAT | SELL | 2023-06-08 | $28K | — | Filing → |